|
|
8000 Jarvis Ave.
Newark, CA 94560 USA
phone:510.456.3700
fax:
|
|
| Symbol |
Private |
| Founded |
2006 |
| Employees |
|
|
|
| www.orayainc.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Non-invasive therapies for diseases of the eye. |
|
| Management |
| Jim Taylor, President and Chief Executive Officer; Michael Gertner, M.D., Michael Gertner, M.D., Founder/Board Member; Steven Hansen, Vice President of Research & Development; Denis O?Shaughnessy, Vice President of Clinical Affairs; Erik Chell, Ph.D., Principal Scientist; Garth Nobis, Vice President, Regulatory Affairs/Quality Assurance |
| |
|
|
| |
|
| Keywords |
| non-invasive, diseases of the eye, IRay� system, AMD, wet age-related macular degeneration |
|
|
|
| Description |
|
Oraya Therapeutics develops non-invasive therapies for diseases of the eye. Its first commercial application, the IRay� system, is currently undergoing clinical trials for the treatment of wet age-related macular degeneration (AMD). |
|
| Products / Services |
The company's first commercial application, the IRay? system, is a noninvasive, low-voltage, stereotactic radiosurgical device designed specifically for office-based ophthalmic use. IRay delivers a precise dose of radiation noninvasively to the macula using a robotic positioning system, a proprietary localizing algorithm and a novel methodology for eye stabilization.
|
|
| Market / Customers |
Affecting central vision, wet AMD is caused by the deterioration of the macula, located in the central portion of the retina. According to AMD Alliance International, AMD is the leading cause of vision loss for people over the age of 50 in the Western world, affecting approximately 25 to 30 million people. Although the wet form of AMD accounts for only 10 to 15 percent of all cases, the risk of severe sight loss is much greater. Wet AMD is responsible for 90 percent of cases of severe vision loss associated with AMD.
|
|
| Funding |
| Oraya is funded by Synergy Life Science Partners, Essex Woodlands Health Ventures, Domain Associates, and Scale Venture Partners. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members